XRAY insider filing: 17,200 options, 3,858 RSUs; 24,047 RSUs gifted

Rhea-AI Filing Summary

Gregory T. Lucier, a director of DENTSPLY SIRONA Inc. (XRAY), reported equity awards and transfers dated 08/08/2025. The filing shows a grant of 3,858 restricted stock units (RSUs) that vest in full one year from the grant date, and a separate transfer/gift of 24,047 RSUs to a family partnership in which the reporting person disclaims beneficial ownership except for any pecuniary interest.

The report also shows an indirect holding of 21,000 shares held in the reporting person's IRA and a grant of 17,200 stock options with an exercise price of $12.96, vesting in one year and expiring on 08/08/2035. The form includes post-transaction beneficial ownership figures for the reporting person and related accounts as provided in the filing.

Positive

• Time-based RSUs and options vest in one year, aligning management incentives with future performance
• Full disclosure of gift to family partnership and IRA holdings increases transparency about beneficial ownership
• Option terms disclosed (17,200 options at $12.96 strike, expiring 08/08/2035) enable clear modeling of potential insider exercises

Negative

• 24,047 RSUs transferred to a family partnership where the spouse is general partner, which may concentrate voting/dispositive power outside direct ownership
• Disclaimed beneficial ownership for the gifted RSUs reduces clarity on true economic vs. voting control without further detail

Insights

Corporate Governance Expert

TL;DR: Routine director compensation with family-partnership transfer noted; governance disclosure is explicit about voting/dispositive power.

The Form 4 documents a typical director equity grant structure: time-based RSUs and stock options that vest one year after grant, aligning compensation with future service. The filing explicitly discloses a 24,047 RSU gift to a family partnership and states the spouse serves as general partner, which the filer notes may control voting and dispositive power. This disclosure is important for transparency around beneficial ownership and potential voting influence.

Securities/Compensation Analyst

TL;DR: Compensation mix of RSUs and options is standard; option strike and vest/expiry schedule are material to option economics.

The disclosure shows a 17,200 option grant with a $12.96 exercise price, exercisable one year after grant and expiring on 08/08/2035, and RSUs that vest in full after one year. For investors modeling dilution or potential insider exercising, the exercise price and amounts are explicit. The IRA holding of 21,000 shares and reported post-transaction beneficial ownership figures should be used as reported when assessing insider holdings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

LUCIER GREGORY T

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/08/2025		A		3,858(1)	A	$0	106,348.434	D
Common Stock	08/08/2025		G		24,047(2)	D	$0	82,301.434	D
Common Stock	08/08/2025		G		24,047(2)	A	$0	24,047	I	By Family Partnership
Common Stock								21,000	I	by Gregory Lucier IRA

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$12.96	08/08/2025		A		17,200		08/08/2026(3)	08/08/2035	Common Stock	17,200	$0	17,200	D

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

2. Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose.

3. Stock Options vest in full one (1) year from date of grant.

	/s/ Jessica Causey, Attorney-in-Fact for Gregory T. Lucier	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Gregory T. Lucier report on Form 4 for XRAY?

The form reports a grant of 3,858 RSUs, a gift/transfer of 24,047 RSUs to a family partnership, an IRA holding of 21,000 shares, and a grant of 17,200 stock options.

When do the RSUs and options reported for XRAY vest or become exercisable?

Both the RSUs and the stock options vest in full one year from the grant date; the options become exercisable on 08/08/2026 and expire on 08/08/2035.

What is the exercise price of the stock options reported by Gregory T. Lucier for XRAY?

The reported stock options have an exercise (conversion) price of $12.96 per share.

Did the reporting person retain beneficial ownership of the gifted RSUs?

The filing states the reporting person disclaims beneficial ownership of the 24,047 RSUs except to the extent of any pecuniary interest; the spouse serves as general partner of the family partnership.

How much shareholding is reported in related accounts on the Form 4?

The form lists post-transaction beneficial ownership figures and specifically discloses an IRA holding of 21,000 shares and indirect ownership via the family partnership of 24,047 shares as reported.